Breast Cancer Clinical Trial
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
Summary
The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.
Eligibility Criteria
Inclusion Criteria:
Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen, anastrozole, letrozole, exemestane).
Age ≥ 60 years
Must have broadband internet access at home (to enable the base for the system to communicate to the Vitality server).
Must have a landline or mobile phone
Exclusion Criteria:
Non-English speaking patients
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10065, United States
How clear is this clinincal trial information?